PRFX
PRF Technologies Ltd.NASDAQHealthcare$2.53+20.48%ClosedMarket Cap: $203,746
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
0.03
P/S
0.00
EV/EBITDA
0.95
DCF Value
$6.43
FCF Yield
-1949.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-47.0%
ROA
-26.7%
ROIC
-33.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| FY 2025 | $17.0K | -4864.7% | $-5.0M | $-4.8M | $-7.47 | — |
| Q2 2025 | $0.00 | NaN% | $-1.2M | $-1.2M | $-13.75 | — |
| Q1 2025 | $0.00 | NaN% | $-1.2M | $-1.2M | $-13.75 | — |
| Q4 2024 | $0.00 | NaN% | $-881.5K | $-885.0K | $-15.00 | — |
| FY 2024 | $0.00 | -Infinity% | $-14.7M | $-14.6M | $-804.00 | — |
| Q3 2024 | $0.00 | NaN% | $-881.5K | $-885.0K | $-15.00 | — |
| Q2 2024 | $0.00 | -Infinity% | $-7.3M | $-7.3M | $-1,264.96 | — |
| Q1 2024 | $0.00 | -Infinity% | $-5.6M | $-5.5M | $-1,630.41 | — |
| Q4 2023 | $0.00 | -Infinity% | $-3.6M | $-4.9M | $-2,096.26 | — |
| FY 2023 | $0.00 | -Infinity% | $-9.6M | $-9.3M | $-4,283.23 | — |
| Q3 2023 | $0.00 | -Infinity% | $-1.4M | $36.0K | $19.81 | — |
| Q2 2023 | $0.00 | -Infinity% | $-2.3M | $-2.2M | $-1,220.58 | — |